Oncology & Cancer

Immune cell linked to better lung cancer survival

Around 48,500 people are diagnosed with lung cancer in the UK each year. New treatments are desperately needed as fewer than 20% of patients survive for five years after diagnosis, and it is the biggest cause of death from ...

Oncology & Cancer

Tracing a cancer's family tree to its roots reveals how tumors grow

Over time, cancer cells can evolve to become resistant to treatment, more aggressive, and metastatic—capable of spreading to additional sites in the body and forming new tumors. The more of these traits that a cancer evolves, ...

Oncology & Cancer

A potential new target for cancer immunotherapies

Tumors can use an enzyme called ART1 to thwart antitumor immune cells, making the enzyme a promising new target for immunity-boosting cancer treatments, according to a study from researchers at Weill Cornell Medicine and Albert ...

Oncology & Cancer

Blood-based tests to detect and monitor lung cancer

To diagnose lung cancer, tumor tissue is collected from a patient and checked for signs of cancer. However, this is not always possible due to tumor location, and can be painful for the patient. For his Ph.D. research, Remco ...

Oncology & Cancer

Talk between immune cells could lead to new cancer vaccine

In the past decade, immunotherapy has helped save the lives of many cancer patients, many with lung cancer, who might have otherwise faced almost certain death sentences. However, only about 20% of patients who received immune ...

page 4 from 20